These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 35127905)

  • 1. Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy.
    Manojlovic N; Savic G; Nikolic B; Rancic N
    World J Clin Cases; 2022 Jan; 10(3):899-918. PubMed ID: 35127905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Prognostic Markers {CEA, Ca19.9, Neutrophil To Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR)} With Progression Free Survival (PFS) in Advanced/Metastatic Gallbladder Carcinoma.
    Naik MD; Kataria SP; Kumar G; Singh R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
    He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
    Front Oncol; 2022; 12():829689. PubMed ID: 35296020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Diagnostic Value Of Combining Inflammatory Cell Ratios With Carcinoembryonic Antigen For Colorectal Cancer.
    Li X; Guo D; Chu L; Huang Y; Zhang F; Li W; Chen J
    Cancer Manag Res; 2019; 11():9631-9640. PubMed ID: 32009818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can carcinoembryonic antigen replace computed tomography in response evaluation of metastatic colorectal cancer?
    Hermunen K; Lantto E; Poussa T; Haglund C; Österlund P
    Acta Oncol; 2018 Jun; 57(6):750-758. PubMed ID: 29388498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in the neutrophil-to-lymphocyte ratio during chemotherapy may predict prognosis in patients with advanced or metastatic colorectal cancer.
    Nemoto T; Endo S; Isohata N; Takayanagi D; Nemoto D; Aizawa M; Utano K; Togashi K
    Mol Clin Oncol; 2021 May; 14(5):107. PubMed ID: 33815795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of related factors of prognosis after surgical treatment of patients with non-metastatic colorectal cancer and construction of a normagram prediction model].
    Liu SX; Zhang L; Shi YK; Han XH
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):167-172. PubMed ID: 35184461
    [No Abstract]   [Full Text] [Related]  

  • 8. The values of systemic immune-inflammation index and neutrophil-lymphocyte ratio in predicting testicular germ cell tumors: A retrospective clinical study.
    Wang S; Yang X; Yu Z; Du P; Cao Y; Ji Y; Ma J; Yang Y
    Front Oncol; 2022; 12():893877. PubMed ID: 36185298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC).
    Sefrioui D; Beaussire L; Gillibert A; Blanchard F; Toure E; Bazille C; Perdrix A; Ziegler F; Gangloff A; Hassine M; Elie C; Bignon AL; Parzy A; Gomez P; Thill C; Clatot F; Sabourin JC; Frebourg T; Benichou J; Bouhier-Leporrier K; Gallais MP; Sarafan-Vasseur N; Michel P; Di Fiore F
    Br J Cancer; 2021 Aug; 125(5):725-733. PubMed ID: 34112948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy.
    Shin K; Jung EK; Park SJ; Jeong S; Kim IH; Lee MA
    World J Gastrointest Oncol; 2021 Aug; 13(8):915-928. PubMed ID: 34457195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response.
    Kim IH; Lee JE; Yang JH; Jeong JW; Ro S; Lee MA
    Asia Pac J Clin Oncol; 2018 Jun; 14(3):239-246. PubMed ID: 29044941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inflammation score predicts the prognosis of gastric cancer patients undergoing Da Vinci robot surgery.
    Chen X; Zhang Y; Liu Z; Song J; Li J
    J Robot Surg; 2024 Mar; 18(1):131. PubMed ID: 38498240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compare the Diagnostic and Prognostic Value of MLR, NLR and PLR in CRC Patients.
    Kang Y; Zhu X; Lin Z; Zeng M; Shi P; Cao Y; Chen F
    Clin Lab; 2021 Sep; 67(9):. PubMed ID: 34542964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of NLR, FIB, CEA and CA19-9 in colorectal cancer].
    Qian X; Wang H; Ren Z; Jin F; Pan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Apr; 55(4):499-505. PubMed ID: 33858062
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients.
    Tang X; Cao Y; Liu J; Wang S; Yang Y; Du P
    Front Mol Biosci; 2020; 7():575483. PubMed ID: 33251247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation-based markers can predict the prognosis of geriatric patients with metastatic colorectal cancer receiving first-line chemotherapy.
    Guo G; Chen X; Cai X; Chen Y; Wang H; Fan L; Bai L; Qiu H; Zhang B
    Transl Cancer Res; 2019 Aug; 8(4):1137-1147. PubMed ID: 35116856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab.
    Passardi A; Azzali I; Bittoni A; Marisi G; Rebuzzi F; Molinari C; Bartolini G; Matteucci L; Sullo FG; Debonis SA; Gallio C; Monti M; Valgiusti M; Muratore M; Rapposelli IG; Ulivi P; Frassineti GL
    Ther Adv Med Oncol; 2023; 15():17588359231212184. PubMed ID: 38107830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Carcinoembryonic Antigen Combined with Multi-Inflammatory Cell Ratios in Colorectal Cancer.
    Liu XC; Dai YL; Huang F; Zhong ZJ; Liu XF
    Dis Markers; 2022; 2022():4889616. PubMed ID: 36061352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.